| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TG THERAPEUTICS, INC. | Director | Common Stock | 265K | $4.22M | $15.94 | Jun 19, 2024 | Direct |
| Nuvectis Pharma, Inc. | Director | Common Stock | 103K | $695K | $6.74 | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS, INC. | Jun 19, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
| NVCT | Nuvectis Pharma, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| TGTX | TG THERAPEUTICS, INC. | Sep 28, 2023 | 1 | $0 | 4 | Sep 29, 2023 | Director |
| NVCT | Nuvectis Pharma, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| TGTX | TG THERAPEUTICS, INC. | Jul 20, 2022 | 1 | $0 | 4 | Jul 22, 2022 | Director |
| NVCT | Nuvectis Pharma, Inc. | May 12, 2022 | 1 | $104K | 4 | May 16, 2022 | Director |
| NVCT | Nuvectis Pharma, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Director |
| NVCT | Nuvectis Pharma, Inc. | Feb 8, 2022 | 0 | $0 | 3 | Feb 8, 2022 | Director |
| TGTX | TG THERAPEUTICS, INC. | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |